{"entity":{"id":"nct07396584","kind":"trial","name":"HMPL-A580 in Participants With Advanced or Metastatic Solid Tumor","aka":[],"tldr":"A phase 1/2 trial of HMPL-A580 in advanced solid tumours, run by Hutchmed, now recruiting.","summary":"HMPL-A580 in Participants With Advanced or Metastatic Solid Tumor is a phase 1/2 interventional study registered as NCT07396584 by Hutchmed, with 186 participants planned, started 2026-03-04 and due to reach its primary completion in 2028-12-31. Interventions recorded: HMPL-A580.","status":"recruiting","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT07396584","url":"https://clinicaltrials.gov/study/NCT07396584"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["metastatic-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":["hutchmed"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"nct":"NCT07396584","phase":"1/2","setting":"A Phase I/Ⅱa Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity and Preliminary Efficacy of HMPL-A580 in Participants With Advanced or Metastatic Solid Tumors","sponsor":"Hutchmed","enrolled":186,"outcomes":[]},"route":"/trials/nct07396584/","neighbours":{"cancer":[{"id":"metastatic-cancer","kind":"cancer","name":"Metastatic cancer (cancer that has spread)","route":"/cancers/metastatic-cancer/"}],"company":[{"id":"hutchmed","kind":"company","name":"Hutchmed","route":"/companies/hutchmed/"}]}}